This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200511-1783OCv1 174/7/831    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ewer, K. Articles by Lalvani, A. Search for Related Content PubMed PubMed Citation Articles by Ewer, K. Articles by Lalvani, A.

Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure to Mycobacterium tuberculosis

Tuberculosis Immunology Group, Nuffield Department of Clinical Medicine, University of Oxford, and John Radcliffe Hospital, Oxford; Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham; and Leicestershire Health Authority, Leicester, United Kingdom

Correspondence and requests for reprints should be addressed to Prof. A. Lalvani, Tuberculosis Immunology Group, Wright Fleming Institute of Infection and Immunity, Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG, UK. E-mail: ajit.lalvani{at}ndm.ox.ac.uk

Rationale: The kinetics of Mycobacterium tuberculosis–specific Th1-type T-cell responses after M. tuberculosis infection are likely to be important in determining clinical outcome.

Objective: To investigate the kinetics of T-cell responses, in the context of a point-source school tuberculosis outbreak, in three groups of contacts who differed by preventive treatment status and tuberculin skin test (TST) results: 38 treated TST-positive students, 11 untreated TST-positive staff, and 14 untreated students with negative or borderline TST results.

Methods: We used the ex vivo IFN- enzyme-linked immunospot assay (ELISpot) to track T cells specific for two region of difference 1 (RD1) antigens, early secretory antigenic target 6 and culture filtrate protein 10, for 18 mo after cessation of tuberculosis exposure.

Main Results: The treated TST-positive students had an average 68% decline in frequencies of RD1-specific IFN-–secreting T cells per year (p < 0.0001) and 6 of 38 students had no detectable RD1-specific T cells by 18 mo. No change in frequencies of these cells was observed in the untreated TST-positive staff (p = 0.38) and none were ELISpot-negative at 18 mo. Of the 14 untreated students, 7 were persistently ELISpot-positive (all of whom had borderline TST results), and 7 became ELISpot-negative (all but one had negative TST results) during follow-up.

Conclusions: The decrease in M. tuberculosis–specific T cells and their disappearance in a proportion of treated students likely reflect declining antigenic and bacterial load in vivo induced by antibiotic treatment. The observed disappearance of M. tuberculosis–specific T cells in the untreated TST-negative contacts suggests that an acute resolving infection may occur in some contacts.

Key Words: IFN- ELISpot • infection • tuberculosis

Related articles in AJRCCM:

Here Today—Gone Tomorrow: The Case for Transient Acute Tuberculosis Infection

Edward A. Nardell and Robert S. Wallis
AJRCCM 2006 174: 734-735. [Full Text]  

This article has been cited by other articles:

				A. K. Detjen, L. Loebenberg, H. M. S. Grewal, K. Stanley, A. Gutschmidt, C. Kruger, N. Du Plessis, M. Kidd, N. Beyers, G. Walzl, et al. Short-Term Reproducibility of a Commercial Interferon Gamma Release Assay Clin. Vaccine Immunol., August 1, 2009; 16(8): 1170 - 1175. [Abstract] [Full Text] [PDF]

				L. Richeldi Diagnosing Latent Tuberculosis Infection: Guess Who's Coming to Dinner? Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 1 - 2. [Full Text] [PDF]

				E. J. Rubin The Granuloma in Tuberculosis -- Friend or Foe? N. Engl. J. Med., June 4, 2009; 360(23): 2471 - 2473. [Full Text] [PDF]

				C. R. Sander, A. A. Pathan, N. E. R. Beveridge, I. Poulton, A. Minassian, N. Alder, J. Van Wijgerden, A. V. S. Hill, F. V. Gleeson, R. J. O. Davies, et al. Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 724 - 733. [Abstract] [Full Text] [PDF]

				G. H. Bothamley, L. Ditiu, G. B. Migliori, C. Lange, and TBNET contributors Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey Eur. Respir. J., October 1, 2008; 32(4): 1023 - 1030. [Abstract] [Full Text] [PDF]

				K. Borgen, B. Koster, H. Meijer, V. Kuyvenhoven, M. van der Sande, and F. Cobelens Evaluation of a large-scale tuberculosis contact investigation in the Netherlands Eur. Respir. J., August 1, 2008; 32(2): 419 - 425. [Abstract] [Full Text] [PDF]

				R. Hussain, N. Talat, F. Shahid, and G. Dawood Longitudinal Tracking of Cytokines after Acute Exposure to Tuberculosis: Association of Distinct Cytokine Patterns with Protection and Disease Development Clin. Vaccine Immunol., December 1, 2007; 14(12): 1578 - 1586. [Abstract] [Full Text] [PDF]

				W. P. J. Franken, B. F. P. J. Koster, A. W. J. Bossink, S. F. T. Thijsen, J. J. M. Bouwman, J. T. van Dissel, and S. M. Arend Follow-Up Study of Tuberculosis-Exposed Supermarket Customers with Negative Tuberculin Skin Test Results in Association with Positive Gamma Interferon Release Assay Results Clin. Vaccine Immunol., September 1, 2007; 14(9): 1239 - 1241. [Abstract] [Full Text] [PDF]

				E. M. S. Leyten, S. M. Arend, C. Prins, F. G. J. Cobelens, T. H. M. Ottenhoff, and J. T. van Dissel Discrepancy between Mycobacterium tuberculosis-Specific Gamma Interferon Release Assays Using Short and Prolonged In Vitro Incubation Clin. Vaccine Immunol., July 1, 2007; 14(7): 880 - 885. [Abstract] [Full Text] [PDF]

				A. Lalvani Diagnosing Tuberculosis Infection in the 21st Century: New Tools To Tackle an Old Enemy Chest, June 1, 2007; 131(6): 1898 - 1906. [Abstract] [Full Text] [PDF]

				A. F. Luetkemeyer, E. D. Charlebois, L. L. Flores, D. R. Bangsberg, S. G. Deeks, J. N. Martin, and D. V. Havlir Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 737 - 742. [Abstract] [Full Text] [PDF]

				M. Pai and D. Menzies The New IGRA and the Old TST: Making Good Use of Disagreement Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 529 - 531. [Full Text] [PDF]

				W. W. Yew and C. C. Leung Update in Tuberculosis 2006 Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 541 - 546. [Full Text] [PDF]

				D. Menzies, M. Pai, and G. Comstock Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research Ann Intern Med, March 6, 2007; 146(5): 340 - 354. [Abstract] [Full Text] [PDF]

				C. B. E. Chee, K. W. KhinMar, S. H. Gan, T. M. S. Barkham, M. Pushparani, and Y. T. Wang Latent Tuberculosis Infection Treatment and T-Cell Responses to Mycobacterium tuberculosis-specific Antigens Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 282 - 287. [Abstract] [Full Text] [PDF]

				A. Lalvani, K. Millington, and K. Ewer Should Individuals Who Are Tuberculin Skin Test Negative and Positive to RD1-IFN-{gamma} Assay Receive Preventive Therapy? Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 199 - 199. [Full Text] [PDF]

				L. Richeldi Should Individuals Who Are Tuberculin Skin Test Negative and Positive to RD1-IFN-{gamma} Assay Receive Preventive Therapy? Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 200 - 200. [Full Text] [PDF]

				E. Girardi, D. Goletti, and G. Ippolito Should Individuals Who Are Tuberculin Skin Test Negative and Positive to RD1-IFN-{gamma} Assay Receive Preventive Therapy? Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 198a - 199. [Full Text] [PDF]